Live Music Stocks Soar on COVID-19 Vaccine Breakthrough

Stock prices for live music companies skyrocketed Monday morning on news that a COVID-19 vaccine was found to be 90% effective. At 9:15 am ET, just 30 minutes after Pfizer’s press release with its vaccine trial results, Live Nation was +20.8% to $67.73, Madison Square Garden Entertainment was +21.4% to $84.44 and Germany concert promoter CTS Eventim was +23.5% to $51.90.

Source: Live Music Stocks Soar on COVID-19 Vaccine Breakthrough

Post a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Get the latest RightsTech news and analysis delivered directly in your inbox every week
We respect your privacy.